Lunai Bioworks Inc. LNAI
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 48.80% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 48.80% | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 48.80% | -- | |||
| SG&A Expenses | 54.93% | -19.53% | |||
| Depreciation & Amortization | 170.00% | -2.65% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 49.83% | -20.58% | |||
| Operating Income | -49.86% | 21.72% | |||
| Income Before Tax | 21.81% | -42.90% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 21.81% | -42.90% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 21.81% | -42.90% | |||
| EBIT | -49.86% | 21.72% | |||
| EBITDA | -50.43% | 22.06% | |||
| EPS Basic | 46.18% | -34.26% | |||
| Normalized Basic EPS | 10.58% | 24.65% | |||
| EPS Diluted | 46.18% | -34.26% | |||
| Normalized Diluted EPS | 10.58% | 24.65% | |||
| Average Basic Shares Outstanding | 45.32% | 6.44% | |||
| Average Diluted Shares Outstanding | 45.32% | 6.44% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||